Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03086200 · ClinicalTrials.gov registry record · NA
Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 263
- Enrollment target
NCT03086200 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 263 participants.
The verdict
NCT03086200, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 263 participants
- Enrollment target
Study Summary
CCTG 603 is an open-label, two-arm, randomized (1:1) clinical demonstration project to determine if brief Motivational Interviewing (MI-B) added to a text-message based adherence intervention (iTAB) improves adherence to PrEP among transgender persons.
Interventions
- BEHAVIORAL brief Motivational Interviewing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 263 participants |
| Start Date | 2017-06-23 |
| Est. Completion | 2020-12-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03086200
The ClinicalTrials.gov registry entry for NCT03086200 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 263 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which brief Motivational Interviewing is the first listed.
NCT03086200 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03086200 about?
NCT03086200 is a clinical study titled "Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals". CCTG 603 is an open-label, two-arm, randomized (1:1) clinical demonstration project to determine if brief Motivational Interviewing (MI-B) added to a text-message based adherence intervention (iTAB) improves adherence to PrEP among transgender persons.
What is the current status of trial NCT03086200?
This trial is currently completed. It is a NA study. The enrollment target is 263 participants. The study started on 2017-06-23. Estimated completion is 2020-12-18.
What interventions are being tested in trial NCT03086200?
The interventions under investigation include: brief Motivational Interviewing (BEHAVIORAL).
Who is sponsoring clinical trial NCT03086200?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.